Autonomy of the air arm /

First published in 1950 under title: The question of autonomy for the United States air arm, 1907-1945.

Carl A. Spaatz and the air war in Europe /

An expansion of the author's thesis.

TECOM, air defense testing.

Mode of access: Internet.

Base winterization guide.

"Cold hard facts : Minot Air Force Base winterization guide"--p. following t.p.

Joint operational concept for air base ground defense : military operations.

Mode of access: Internet.

United States standard facilities flight check manual.

Mode of access: Internet.

Military air transportation : twenty-eighth report by the Committee on Government Operations.

Mode of access: Internet.

Examination and review of a pamphlet printed and secretly circulated by M. E. Gorostiza, late envoy extraordinary from Mexico; previous to his departure from the United States, and by him entitled "Correspondence between the legation extraordinary of Mexico and the Department of state of the United States. Respecting the passage of the Sabine, by the troops under the command of General Gaines."

Includes a translation of Gorostiza's pamphlet (p. [165]-188)

Compressed air.

"12 January 1990."

Organizational, direct support, and general support maintenance repair parts and special tools lists (including depot maintenance repair parts and special tools) : air conditioner, 25,000 Btu, electric motor driven, 120/208V, 3 phase, 50/60 Hz, 4 wire, Ellis Watts model MOAC-336, NSN 4120-01-030-6883.

Includes index.

Operator, organizational, direct support and general support manual : air conditioner, 25,000 BTU, electric motor driven, 120/208V, 3 phase, 50/60 Hz, 4 wire, Ellis watts, model MOAC-336, NSN 4120-01-030-6883.

"February 1977."

Study of Military Air Transport Service. Hearings before a special subcommittee, Eighty-fifth Congress, second session. May 19, June 12-13, 1958.

Mode of access: Internet.

Medical support of the Army Air Forces in World War II,

Mode of access: Internet.

The Evolution of Chimpanzee Sanctuaries in the United States

Chimpanzees are native only to the jungles of equatorial Africa, but for the last hundred years, they have also lived in captivity in the United States, most commonly in biomedical research laboratories, but also at Air Force bases for experiments for the space program, at accredited and unaccredited zoos, at circuses, as performers in Hollywood and even in private homes and backyards as pets. But that has been gradually evolving over the last few decades, as more and more chimpanzees move to newly-established chimpanzee sanctuaries. That transition was already underway even before the announcement by the National Institutes of Health (NIH) last year that it will retire all of its remaining chimpanzees from labs to sanctuaries. By thoroughly examining the evolution of these sanctuaries leading up to that seminal decision, along with the many challenges they face, including money, medical care, conflicting philosophies on the treatment of animals and the pitfalls that have led other sanctuaries to the brink of ruin, we can take away a better understanding of why chimpanzee sanctuaries are needed and why caretakers of other animal species are now looking to the chimpanzee sanctuary movement as a model to show how animals can be cared for in retirement.

Clinical End Points and Response Criteria in Mycosis Fungoides and Sezary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer

Mycosis fungoides (MF) and Sezary syndrome (SS), the major forms of cutaneous T-cell lymphoma, have unique characteristics that distinguish them from other types of non-Hodgkin`s lymphomas. Clinical trials in MF/SS have suffered from a lack of standardization in evaluation, staging, assessment, end points, and response criteria. Recently defined criteria for the diagnosis of early MF, guidelines for initial evaluation, and revised staging and classification criteria for MF and SS now offer the potential for uniform staging of patients enrolled in clinical trials for MF/SS. This article presents consensus recommendations for the general conduct of clinical trials of patients with MF/SS as well as methods for standardized assessment of potential disease manifestations in skin, lymph nodes, blood, and visceral organs, and definition of end points and response criteria. These guidelines should facilitate collaboration among investigators and collation of data from sponsor-generated or investigator-initiated clinical trials involving patients with MF or SS. J Clin Oncol 29:2598-2607. (C) 2011 by American Society of Clinical Oncology